Telomerase protects cancer-prone human cells from chromosomal instability and spontaneous immortalization

Cancer Biology and Therapy

Volumn 1, Issue 4, 2002, Pages 390-397

  Elmore, Lynne W ^a   Turner, Kristi C ^a   Gollahon, Lauren S ^b   Landon, Melissa R ^a   Jackson Cook, Colleen K ^a   Holt, Shawn E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY   (United States)

Author keywords

Cancer; Immortality; Senescence; Telomerase; Telomere

Indexed keywords

PROTEIN P53; TELOMERASE;

ADULT; ARTICLE; BREAST; CELL TRANSFORMATION; CHROMOSOME; CHROMOSOME ABERRATION; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TIME; TRANSACTIVATION; ULTRASTRUCTURE; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; BREAST; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; LI-FRAUMENI SYNDROME; PRECIPITIN TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TELOMERASE; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 0141857636     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.1.4.13     Document Type: Article

References (44)

1. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Geron 1992; 27: 83-9.
2. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345:458-60.
3. Hastie N, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire, RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346:866-8.
4. Watson JD. Origin of concatameric T4 DNA. Nat New Biol (1972); 239: 197-201.
5. Olovnikoff AM Principle of marginotomy in template synthesis of oligonucleotides. Doklady Biochem 1971; 201:394-7.
6. Shay JW, Bacchetti, S. A survey of telomerase activity in human cancer. Eur J Cancer 1977; 33:787-91.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West M.D, Ho PL, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266:2011-5.
8. Counter CM, Avilion AA, LeFeuvr CE, Stewart NG, Greider CW, Harley CB, et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11:1921-9.
9. Jiang Z-R, Jimenez G, Chang E, Frolkis M, Busler B, Sage M, Beeche M et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Gen 1999; 21:1114.
10. Morales CP, Holt SE, Ouellette M, Kaur K.J, Yan Y, Wilson KS et al. Absence of cancer associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999; 21:115-8. (Pubitemid 29036296)
11. Elmore LW, Holt SE Telomerase and telomere stability: A new class of tumor suppressor. Mol Carcin 2000; 28:1-4. (Pubitemid 30252921)
12. Shay JW, Tomlinson G, Piatyszek MA, Gollahon LS Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol Cell Biol 1995; 15:425-32. (Pubitemid 24379941)
13. Boyle JM, Spreadborough A, Greaves MJ, Birch JM, Scott D. Chromosomal instability in fibroblasts derived from Li-Fraumeni syndrome families without TP53 mutations. Br J Cancer 2000; 83:467-72.
14. Boyle JM, Mitchell E.D, Greaves MJ, Roberts SA, Tricker K, Burt E et al. Chromosomal instability is a predominant trait of fibroblasts from Li-Fraumeni families. Br J Cancer 1998; 77: 2181-92. (Pubitemid 28263939)
15. Tainsky MA, Bischoff FZ, Strong LC. Genomic instability due to germline p53 mutations drives neoplastic progression toward cancer in human cells. Cancer Metastasis Rev 1995; 14: 43-8.
16. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager, JB, et al. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 1999; 13:817-26. (Pubitemid 29169841)
17. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein sub-unit hTRT. Nat Genet 1997; 17:498-502. (Pubitemid 27518407)
18. Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods in Cell Sci 1996; 18:237-48.
19. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human chromosomes have long G-rich telomeric overhangs at one end. Genes and Development 1997; 11: 2801-9. (Pubitemid 27481681)
20. Shay JW, Brasiskyte D, Ouelette M, Piatyszek MA, Werbin H, Ying Y, et al. Analysis of telomerase and telomeres. Methods in Molecular Genetics 1994; 5:263-80.
21. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumor cells with defined genetic elements. Nature 1999; 400:464-68. (Pubitemid 29361801)
22. Rooney EE, Czepulkowski BH. In: Prenatal Diagnosis and Tissue Culture in Human Cytogenetics: a Practical Approach. vol. 1. New York: Oxford University Press 1992: p.55-89.
23. Astbury C, Jackson-Cook CK, Culp SH, Paisley TE, Ware JL. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19. Genes Chrom Cancer 2001; 31:143-55. (Pubitemid 32411040)
24. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immobilization. Cell 1997; 90:785-95. (Pubitemid 27357969)
25. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277:955-9. (Pubitemid 27366681)
26. Hiyama E, Hiyama K, Yokoyama T, Shay J. Immunohistochemical detection of telomerase hTERT protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001; 3:17-26. (Pubitemid 32201606)
27. Vaziri H, Squire JA, Pandita TK, Bradley G, Kuba RM, Zhang H, et al. Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts. Mol Cell Biol 1999; 19:2373-9. (Pubitemid 29098294)
28. Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K, Murakami S. Telomerase activity reconstituted in vitro with purified human telomerase reverse transcriptase and human telomerase RNA component. J Biol Chem 2000; 275:22568-73. (Pubitemid 30621849)
29. Bachand F, Autexier C. Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae. J Biol Chem 1999; 274:38027-31. (Pubitemid 30026872)
30. Beattie TL, Zhou W, Robinson M, Harrington L Reconstitution of telomerase activity in vitro. Curr Biol 1998; 8:177-80. (Pubitemid 28091578)
31. Bodnar AG, Ouelette M, Frolkis M, Holt SE, Chiu C-P, Morin GB, et al. Extension of lifespan by introduction of telomerase in normal human cells. Science 1998; 279: 349-52. (Pubitemid 28063364)
32. Vaziri H, Benchimol S Reconstitution of telomerase in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998; 8: 279-82. (Pubitemid 28111458)
33. Srivastava S, Wang S, Tong YA, Pirollo K, Chang EH. Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 1993; 8: 2449-2456. (Pubitemid 23252374)
34. Varley JM, Thorncroft M, McGown G, Appleby J, Kelsey AM, Tricker KJ, et al. A detailed study of loss of heterozygosity on chromosome 17 in tumors from Li Fraumeni patients carrying a mutation to the TP53 gene. Oncogene 1997; 14: 865-71. (Pubitemid 27100031)
35. Waldman T, Kinzler KW, Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 1995; 55: 5187-90.
36. Kuerbitz SJ, Plunkett BS, Walsh WV, Katan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA1992; 89:7491-5.
37. Hackett JA, Feldser DM, Greider CW. Telomere dysfunction increases mutation rate and genomic instability. Cell 2001; 106:275-86.
38. Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, et al. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutations. Cancer Res 1997; 57:1895-902. (Pubitemid 27209718)
39. Antandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000; 406:641-5. (Pubitemid 30641052)
40. Chin L, Artandi SE, Shen Q, Tam A, Lee S-L, Gottlieb GJ, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97:527-38. (Pubitemid 29231175)
41. Kirk KE, Harmon BP, Reichardt IK, Sedat JW, Blackburn EH. Block in anaphase chromosome segregation caused by telomere template mutation. Science 1997; 275: 1478-81. (Pubitemid 27111296)
42. Harrington LA, Greider CW Telomerase primer specificity and chromosome healing. Nature 1991; 353:451-4. (Pubitemid 21912536)
43. Yu G-L, Blackburn EH Developmentally programmed healing of chromosomes by telomerase in Tetrahymena. Cell 1991; 67: 823-832. (Pubitemid 121001495)
44. Wang J, Hannon GJ, Beach DH Risky immortalization by telomerase. Nature 2000; 405:755-6.